Hospital News and Research

RSS

Lung Facts updated with latest evidence on respiratory disease across 21 countries

The International Respiratory Coalition (IRC) has updated its Lung Facts platform with the latest evidence on the burden of respiratory disease across 21 countries, providing policymakers, clinicians and patient advocates with updated data to drive national-level policy action on lung health.

16 Sep 2026

Study illuminates the link between the Epstein-Barr virus and multiple sclerosis

A new study illuminates the connection between the Epstein-Barr virus (EBV) and multiple sclerosis (MS), pointing to a causal role for reactivation of the virus in triggering MS attacks in people with certain genetic risk factors.

16 Sep 2026

AI scribes slash physician documentation time and reduce burnout

Artificial intelligence (AI) scribes can reduce the time physicians spend documenting patient visits by 69.1% during simulated primary care appointments, according to research led by University of Toronto PhD student LaShawn Murray.

15 Sep 2026

US Medicare's new 'Most-Favored-Nation' pricing policy could raise international medicine prices

A new modeling study published in The Lancet suggests that US Medicare's new 'Most-Favored-Nation' pricing policy, which ties what Medicare pays for medicines to prices charged in other high-income countries, could push pharmaceutical manufacturers to raise prices or delay launches.

15 Sep 2026

Study provides a clearer picture of the extent of overdiagnosis in breast cancer screening

When women take part in breast cancer screening, they are informed that screening may detect cancers that would never have caused symptoms or problems during their lifetime. This is known as overdiagnosis.

15 Sep 2026

Wearable electroceutical platform enables remote wireless pain management

A "wearable electroceutical" has been developed that could reduce the need to visit a hospital or rely on painkillers every time pain occurs.

15 Sep 2026

Nationwide safety program successfully cuts hospital-onset MRSA infections

A large-scale, federally funded quality improvement program developed in collaboration with infection prevention experts at the Johns Hopkins Armstrong Institute for Patient Safety and Quality was associated with a 65% reduction in hospital-onset bloodstream infections caused by methicillin-resistant Staphylococcus aureus (MRSA) among participating hospital units.

15 Sep 2026

Final results from PAPILLON trial confirm long-term survival in a subset of lung cancer

Final results from the landmark PAPILLON trial, which changed the standard of care for a difficult-to-treat rare form of lung cancer, confirm that amivantamab, when added to chemotherapy, provides durable clinical benefit and the longest median overall survival reported to date for people with the disease.

15 Sep 2026

Air pollution linked to higher risks of glaucoma and cataract

People who live in areas with higher levels of air pollution are more likely to develop glaucoma and cataract, according to a large study presented today (Monday) at the 44th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS).

15 Sep 2026

Smartphone imaging accurately supports remote cataract referral decisions

Researchers have found a high level of agreement between cataract referral decisions based on smartphone images reviewed remotely and those made by ophthalmologists examining patients in person at rural eye camps.

15 Sep 2026

Sacituzumab govitecan combination misses progression-free survival endpoint in metastatic NSCLC

Sacituzumab govitecan (SG) plus pembrolizumab did not demonstrate a statistically significant improvement in progression-free survival compared with pembrolizumab alone as first-line treatment for patients with metastatic non-small cell lung cancer (NSCLC) and PD-L1 tumor proportion score (TPS) of 50% or greater, according to primary results from the Phase 3 EVOKE-03/KEYNOTE-D46 trial presented at the International Association for the Study of Lung Cancer (IASLC) 2026 World Conference on Lung Cancer (WCLC).

15 Sep 2026

Ivonescimab shows significant survival benefit for patients with PD-L1-positive NSCLC

Ivonescimab significantly prolonged overall survival compared with pembrolizumab as first-line treatment for patients with PD-L1-positive advanced non-small cell lung cancer (NSCLC), according to a prespecified interim analysis of the phase 3 HARMONi-2 trial presented today at the IASLC 2026 World Conference on Lung Cancer.

14 Sep 2026

Ris-Rez improves survival in patients with relapsed small-cell lung cancer

Results from the randomized Phase III ARTEMIS-008 trial show that risvutatug rezetecan (Ris-Rez), a B7-H3-directed antibody-drug conjugate, significantly improved overall survival compared with topotecan in patients with relapsed small-cell lung cancer (SCLC) whose disease progressed on or after platinum-based chemotherapy.

14 Sep 2026

European registry shows continued improvements in cataract surgery outcomes

A total of 363,039 cataract surgeries performed in 12 European countries in 2024 have been recorded in the European Registry of Quality Outcomes for Cataract and Refractive Surgery (EUREQUO), according to the latest figures presented at the 44th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) today (Tuesday).

14 Sep 2026

Eye scans detect signs of atrial fibrillation years before diagnosis

People with atrial fibrillation have signs of the condition in the retinas of their eyes that can be detected as early as four years before diagnosis, finds a new study led by University College London (UCL) and Moorfields researchers.

14 Sep 2026

More hospitals are adopting AI, yet the access gap is proving hard to close

A national analysis of 6,166 US hospitals found that specific workflow AI capabilities were associated with higher sepsis bundle completion rates and lower 30-day pneumonia mortality, whereas robotics showed narrower procedural associations. Geographic access remained highly uneven, with about 114.6 million people in the access-analysis population living more than 30 minutes from an AI-enabled hospital, although the observational design prevents causal conclusions.

14 Sep 2026

More data, more answers? A 1.9 million-person health study shows why scale has limits

Researchers analyzed phenotypic and linked health-record data from more than 1.9 million adults in Our Future Health, comparing demographic characteristics, disease patterns, clinical associations, and rare-condition case counts with national data and other major cohorts. The cohort's size provides unusually large samples for many common and less common conditions, although its demographic composition and current data sources require careful consideration when interpreting population-level estimates.

14 Sep 2026

Subcutaneous tarlatamab exhibits low toxicity rates in phase 1b trial

Subcutaneous administration of tarlatamab was well tolerated and demonstrated preliminary antitumor activity in patients with previously treated extensive-stage small cell lung cancer (ES-SCLC), according to findings from the phase 1b DeLLphi-308 study presented at the International Association for the Study of Lung Cancer (IASLC) 2026 World Conference on Lung Cancer (WCLC).

12 Sep 2026

Rare cortical neurons actively promote the transition into sleep

What makes the brain fall asleep? For nearly a century, scientists have looked to structures deep within the brain for the answer.

11 Sep 2026

FDA clears trial of dual-targeted CAR T-cell therapy for cancer

The U.S. Food and Drug Administration this week granted permission for investigators at the University of Colorado Anschutz to conduct a clinical trial testing genetically engineered immune cells in adults with advanced colorectal cancer and pediatric patients with solid cancers who have exhausted standard treatment options.

11 Sep 2026

Previous
1
...
22
23
24
25
26
27
28
...
4382
Next

Hospital News and Research

Lung Facts updated with latest evidence on respiratory disease across 21 countries

Study illuminates the link between the Epstein-Barr virus and multiple sclerosis

AI scribes slash physician documentation time and reduce burnout

US Medicare's new 'Most-Favored-Nation' pricing policy could raise international medicine prices

Study provides a clearer picture of the extent of overdiagnosis in breast cancer screening

Wearable electroceutical platform enables remote wireless pain management

Nationwide safety program successfully cuts hospital-onset MRSA infections

Final results from PAPILLON trial confirm long-term survival in a subset of lung cancer

Air pollution linked to higher risks of glaucoma and cataract

Smartphone imaging accurately supports remote cataract referral decisions

Sacituzumab govitecan combination misses progression-free survival endpoint in metastatic NSCLC

Ivonescimab shows significant survival benefit for patients with PD-L1-positive NSCLC

Ris-Rez improves survival in patients with relapsed small-cell lung cancer

European registry shows continued improvements in cataract surgery outcomes

Eye scans detect signs of atrial fibrillation years before diagnosis

More hospitals are adopting AI, yet the access gap is proving hard to close

More data, more answers? A 1.9 million-person health study shows why scale has limits

Subcutaneous tarlatamab exhibits low toxicity rates in phase 1b trial

Rare cortical neurons actively promote the transition into sleep

FDA clears trial of dual-targeted CAR T-cell therapy for cancer

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News